Oral Contraception Inducing Bullous Pemphigoid in an Adolescent

Main Article Content

Margaret C Wheless
University of Tennessee Health Science Center

Blake Reid Zelickson
University of Tennessee Health Science Center

Tejesh S Patel
University of Tennessee Health Science Center

Allison V Jones
University of Tennessee Health Science Center

Keywords

bullous pemphigoid, drug reactions, vesiculobullous dermatoses

Abstract

Abstract not available.

References

1. Amber, K., Murrell, D., Schmidt, E., Joly, P. and Borradori, L. (2017). Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Clinical Reviews in Allergy & Immunology, 54(1), pp.26-51.

2. Honeyman, J., Eguiguren, G., Pinto, A., Honeyman, A., de la Parra, M. and Navarrete, W. (1981). Bullous dermatoses of pregnancy. Archives of Dermatology, 117(5), pp.264-267.

3. Patsatsi, A., Kyriakou, A. and Werth, V. (2019). Bullous pemphigoid in adolescence. Pediatric Dermatology, 36(2), pp.184-188.

4. Polansky, M., Eisenstadt, R., DeGrazia, T., Zhao, X., Liu, Y. and Feldman, R. (2019). Rituximab Therapy in Patients with Bullous Pemphigoid: A Retrospective Study of 20 Patients. Journal of the American Academy of Dermatology.

5. Stavropoulos, P., Soura, E. and Antoniou, C. (2014). Drug-induced pemphigoid: a review of the literature. Journal of the European Academy of Dermatology and Venereology, 28(9), pp.1133-1140.

6. Tandon, V., Mahajan, A. and Sharma, S. (2008). Tibolone induced Bullous pemphigoid. JK Science Journal, 10(1), pp.26-27.

Article Sidebar

PDF
Published
Mar 8, 2020
DOI https://doi.org/10.25251/skin.4.2.16

Article Details

How to Cite
[1]
Wheless, M.C., Zelickson, B.R., Patel, T.S. and Jones, A.V. 2020. Oral Contraception Inducing Bullous Pemphigoid in an Adolescent. SKIN The Journal of Cutaneous Medicine. 4, 2 (Mar. 2020), 177–179. DOI:https://doi.org/10.25251/skin.4.2.16.
Issue
Vol. 4 No. 2 (2020)
Section
Short Communications
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Author Biographies

Margaret C Wheless, University of Tennessee Health Science Center

MS4, Medical Student

Blake Reid Zelickson, University of Tennessee Health Science Center

Dermatology Resident

Tejesh S Patel, University of Tennessee Health Science Center

Department Chair, Dermatology

Allison V Jones, University of Tennessee Health Science Center

Assistant Professor, Dermatology